Stratos Wealth Partners, Ltd. Agios Pharmaceuticals, Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$42.73 - $76.53 $8,546 - $15,306	-200 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$71.67 - $91.95 $14,334 - $18,390	200 New	200 $15,000
Q2 2018 Aug 13, 2018	SELL	$73.22 - $99.55 $14,644 - $19,910	-200 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $10,424 - $14,466	200	200 $11,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.